These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 21937451)
1. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability. Sarma NJ; Yaseen NR J Biol Chem; 2011 Nov; 286(45):38989-9001. PubMed ID: 21937451 [TBL] [Abstract][Full Text] [Related]
2. Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins. Sarma NJ; Yaseen NR PLoS One; 2013; 8(6):e67032. PubMed ID: 23840580 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins. Takeda A; Sarma NJ; Abdul-Nabi AM; Yaseen NR J Biol Chem; 2010 May; 285(21):16248-57. PubMed ID: 20233715 [TBL] [Abstract][Full Text] [Related]
4. Dissection of the transformation of primary human hematopoietic cells by the oncogene NUP98-HOXA9. Yassin ER; Sarma NJ; Abdul-Nabi AM; Dombrowski J; Han Y; Takeda A; Yaseen NR PLoS One; 2009 Aug; 4(8):e6719. PubMed ID: 19696924 [TBL] [Abstract][Full Text] [Related]
5. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599 [TBL] [Abstract][Full Text] [Related]
6. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells. Takeda A; Goolsby C; Yaseen NR Cancer Res; 2006 Jul; 66(13):6628-37. PubMed ID: 16818636 [TBL] [Abstract][Full Text] [Related]
7. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Calvo KR; Sykes DB; Pasillas MP; Kamps MP Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612 [TBL] [Abstract][Full Text] [Related]
8. MLL is essential for NUP98-HOXA9-induced leukemia. Shima Y; Yumoto M; Katsumoto T; Kitabayashi I Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005 [TBL] [Abstract][Full Text] [Related]
9. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells. Ghannam G; Takeda A; Camarata T; Moore MA; Viale A; Yaseen NR J Biol Chem; 2004 Jan; 279(2):866-75. PubMed ID: 14561764 [TBL] [Abstract][Full Text] [Related]
10. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis. Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091 [TBL] [Abstract][Full Text] [Related]
11. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9. Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533 [TBL] [Abstract][Full Text] [Related]
12. Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation. Chung KY; Morrone G; Schuringa JJ; Plasilova M; Shieh JH; Zhang Y; Zhou P; Moore MA Cancer Res; 2006 Dec; 66(24):11781-91. PubMed ID: 17178874 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system. Mayotte N; Roy DC; Yao J; Kroon E; Sauvageau G Blood; 2002 Dec; 100(12):4177-84. PubMed ID: 12393433 [TBL] [Abstract][Full Text] [Related]
14. Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif. Yassin ER; Abdul-Nabi AM; Takeda A; Yaseen NR Leukemia; 2010 May; 24(5):1001-11. PubMed ID: 20339440 [TBL] [Abstract][Full Text] [Related]
16. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor. Hirose K; Abramovich C; Argiropoulos B; Humphries RK Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245 [TBL] [Abstract][Full Text] [Related]
17. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins. Nakamura T Int J Hematol; 2005 Jul; 82(1):21-7. PubMed ID: 16105755 [TBL] [Abstract][Full Text] [Related]
18. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Gough SM; Slape CI; Aplan PD Blood; 2011 Dec; 118(24):6247-57. PubMed ID: 21948299 [TBL] [Abstract][Full Text] [Related]
19. Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation. Quéré R; Karlsson G; Hertwig F; Rissler M; Lindqvist B; Fioretos T; Vandenberghe P; Slovak ML; Cammenga J; Karlsson S Blood; 2011 Jun; 117(22):5918-30. PubMed ID: 21471525 [TBL] [Abstract][Full Text] [Related]
20. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Wang GG; Cai L; Pasillas MP; Kamps MP Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]